Wells Pharmacy Network LLC recalls Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Phar
Recalled January 11, 2017 · FDA recall D-0407-2017 · Wells Pharmacy Network
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
a) 257 vials and b) 460 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility
Product
Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
Manufacturer(s)
Wells Pharmacy Network LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →